AzTrials
AzTrials

Exercise TherapyLIFDINCT06938568

Personalized Physical Back Training Program to Improve Physical Functioning in People With Non-specific Low Back Pain

A study testing Personalized back exercises and Non-personalized back exercises in people with Exercise Therapy and Low Back Pain, run by Claudio Perret at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Personalized medicine and individualized therapeutic approaches are prominent in current research. But are these approaches also effective for treating non-specific low back pain (NSLBP)? NSLBP is one of the most common musculoskeletal issues, which can impair physical well-being, reduce the quality of life, and limit… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Exercise Therapy, Low Back Pain
What is being tested?
Personalized back exercises and Non-personalized back exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteSwitzerland
Study dates
1 May 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Access to the University Sports of the Lucerne Universities (i.e., students, employees, alumni, subscribers)
  • NSLBP for at least 6 weeks
  • Activity limiting NSLBP (at least one activity with a PSFS Score of ≤ 50/100 on a scale from 0 = unable to perform due to NSLBP to 100 = able to perform at the same level as before NSLBP)
  • Age between 18 and 65 years
  • Understand the German language
  • Willing to participate in the study
  • Written informed consent

Who cannot join

  • Specific LBP
  • Red flags associated with any serious pathology or specific LBP,
  • Being on a waiting list for or less than 12 months post any surgery of the lower back
  • Pregnancy or given birth within the last 12 months
  • Diagnosed central neurological disease
  • Not allowed to exercise
  • Participant in the feasibility study
  • Expecting to be absent for more than 2 weeks during the intervention period

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Claudio Perret, PhD contact

+41419396650

claudio.perret@unilu.ch

Andrea M Aegerter, PhD contact

+41412295739

andrea.aegerter@unilu.ch

Switzerland1 site, 1 recruiting
  • University of Lucerne, Faculty of Health Sciences and Medicine, University Research Centre Health and Society

    Lucerne, Canton of Lucerne, 6002

    Claudio Perret, PhD, +41419396650, claudio.perret@unilu.ch

    Andrea M Aegerter, PhD, +41412295739, andrea.aegerter@unilu.ch

    Recruiting

Other trials in Switzerland

About this study

Personalized medicine and individualized therapeutic approaches are prominent in current research. But are these approaches also effective for treating non-specific low back pain (NSLBP)? NSLBP is one of the most common musculoskeletal issues, which can impair physical well-being, reduce the quality of life, and limit physical functioning. Additionally, it contributes to substantial direct and indirect healthcare costs, such as frequent doctor visits and work absences. Despite NSLBP being a significant burden for both individuals and society, effective alleviation methods remain unclear. The investigators' research project therefore aims to investigate whether personalized therapy, specifically a personalized physical back training program, can effectively address NSLBP. Within the context of NSLBP, the investigators' specific aim is to improve physical functioning as this outcome is considered relevant from all perspectives, including those of patients, clinical professionals, researchers, and guidelines.

Being tested
Personalized back exercises, Non-personalized back exercises
Keywords
Physical Functioning, Exercise
Medical subject headings
Low Back Pain, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personalized back exercisesOther

    The study intervention is a 12-week personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment.

    An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).

  • Non-personalized back exercisesOther

    The active control intervention is a 12-week non-personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment.

    An initial one-on-one training session will take place to familiarize participants with the back training program, corresponding to the first week's session of the 12-week intervention period. During the 12-week intervention period, the training comprises one supervised group session per week, lasting 30 minutes, along with three individual unsupervised sessions, each lasting 10-15 minutes. Our procedures ensures that both participants and instructors are blinded to the group allocation, allowing both groups to train together (e.g., mixed training groups).

Study groups in NCT06938568
Study groupRoleWhat they receive
Personalized back exercisesExperimentalThe study intervention is a 12-week personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment.
Receives: Other: Personalized back exercises
Non-personalized back exercisesActive comparatorThe active control intervention is a 12-week non-personalized physical back training program. It consists of six to eight exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment.
Receives: Other: Non-personalized back exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-rated physical functioning

    Change in Patient-Specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 100 (able to perform at the same level as before NSLBP)

    Measured: Baseline to 12 weeks

Secondary outcomes (6)
  1. Self-rated physical functioning

    Change in Patient-Specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 100 (able to perform at the same level as before NSLBP)

    Measured: Baseline to 4, 8, and 24 weeks

  2. Self-rated physical functioning (RMDQ)

    Change in Roland Morris Disability Questionnaire (RMDQ). Range from 0 (no disability) to 24 (maximum disability).

    Measured: Baseline to 4, 8, 12, and 24 weeks

  3. Health-related quality of life (EQ-VAS)

    Change in EQ Visual Analogue Scale (EQ-VAS). Range from 0 (lowest health-related quality of life) to 100 (highest health-related quality of life).

    Measured: Baseline to 4, 8, 12, and 24 weeks

  4. Health-related quality of life (EQ-5D-5L)

    Change in 5-Level EuroQoL5D version (EQ-5D-5L). Range from 0 (lowest health-related quality of life) to 1 (highest health-related quality of life).

    Measured: Baseline to 4, 8, 12, and 24 weeks

  5. Pain intensity (NRS)

    Change in pain intensity (11-point Numeric Rating Scale, NRS). Range from 0 (no pain) to 10 (pain as bad as you can imagine). Recall period: 7 days.

    Measured: Baseline to 4, 8, 12, and 24 weeks

  6. Safety outcome

    Number of serious adverse events (SAE) and adverse events (AE) that are deemed possibly, probably, or definitely related to the intervention (according to our protocol and ClinO, Art. 63, Switzerland).

    Measured: During the 12 week intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2025
  2. Study start1 May 2025
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06938568
Sponsor's protocol ID
2024-01285
Other IDs
63674
Acronym
LIFDI
Status last verified
May 2025
First submitted
14 Apr 2025
Last updated
4 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: It is anticipated that the investigators will make encrypted individual participant data (IPD) available via a data repository and, additionally, upon reasonable request to the Principal Investigator. In both cases, only data from participants who have provided informed consent for data sharing will be made available.

Questions about this trial

What is this clinical trial studying?

A study testing Personalized back exercises and Non-personalized back exercises in people with Exercise Therapy and Low Back Pain, run by Claudio Perret at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Claudio Perret, PhD (+41419396650, claudio.perret@unilu.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-rated physical functioning (time frame: Baseline to 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in